Norges Bank bought a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 8,229,093 shares of the real estate investment trust’s stock, valued at approximately $166,804,000. Norges Bank owned about 1.18% of Healthpeak Properties as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Harvest Fund Management Co. Ltd acquired a new stake in shares of Healthpeak Properties during the fourth quarter worth $30,000. Groupama Asset Managment acquired a new stake in Healthpeak Properties in the 3rd quarter worth about $37,000. Continuum Advisory LLC purchased a new stake in Healthpeak Properties in the 3rd quarter valued at about $44,000. AdvisorNet Financial Inc increased its stake in shares of Healthpeak Properties by 34.5% during the 4th quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock valued at $44,000 after acquiring an additional 563 shares during the last quarter. Finally, Kestra Investment Management LLC purchased a new position in shares of Healthpeak Properties during the 4th quarter worth about $45,000. 93.57% of the stock is owned by hedge funds and other institutional investors.
Healthpeak Properties Price Performance
Shares of DOC stock opened at $20.23 on Tuesday. The firm has a fifty day simple moving average of $20.22 and a 200-day simple moving average of $21.08. The company has a market capitalization of $14.15 billion, a PE ratio of 57.79, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a twelve month low of $17.80 and a twelve month high of $23.26. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96.
Healthpeak Properties Increases Dividend
Wall Street Analyst Weigh In
Several equities analysts recently commented on DOC shares. Mizuho dropped their price target on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Thursday, December 5th. StockNews.com upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Saturday, March 22nd. Robert W. Baird dropped their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Tuesday, February 11th. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective on the stock in a research note on Wednesday, January 15th. Finally, Wedbush decreased their target price on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, February 14th. Four equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $23.92.
About Healthpeak Properties
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Recommended Stories
- Five stocks we like better than Healthpeak Properties
- Business Services Stocks Investing
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- 3 Warren Buffett Stocks to Buy Now
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- How Investors Can Find the Best Cheap Dividend Stocks
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.